CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the Chairman of the Board, Jørgen Flemming Ladefoged, has purchased 22,000 stocks in the Company.

Chairman of the Board of Directors of CS MEDICA, Jørgen Flemming Ladefoged, has purchased 22,000 shares in the open market at a price of DKK 7,05 per share, corresponding to a total purchase of 155,100 DKK. The transaction has been disclosed in the Danish financial supervisory register. Following the transaction, Jørgen Flemming Ladefoged owns 22,000 CS MEDICA shares.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.